P. Timmers

发表

Surgical staging and treatment of early ovarian cancer: long-term analysis from a randomized trial.

C. Coens, S. Pecorelli, B. Trimbos, 2010, Journal of the National Cancer Institute.

Clear Cell Carcinoma Compared to Serous Carcinoma in Early Ovarian Cancer: Same Prognosis in a Large Randomized Trial

A. Zwinderman, J. Trimbos, I. Vergote, 2009, International Journal of Gynecologic Cancer.

Chemotherapy for early ovarian cancer

J. Trimbos, P. Timmers, 2004, Current opinion in obstetrics & gynecology.

Understanding the problem of inadequately staging early ovarian cancer.

A. Zwinderman, J. Trimbos, I. Vergote, 2010, European journal of cancer.

Long-term follow-up confirms a survival advantage of the paclitaxel–cisplatin regimen over the cyclophosphamide–cisplatin combination in advanced ovarian cancer

M. Piccart, K. Swenerton, I. Vergote, 2003, International Journal of Gynecologic Cancer.

Recurrence Rate in Vulvar Carcinoma in Relation to Pathological Margin Distance

C. Burger, P. Timmers, S. M. Groenen, 2010, International Journal of Gynecologic Cancer.

Human Papillomavirus Infection in Squamous Cell Carcinoma of the Vulva, in Various Synchronous Epithelial Changes and in Normal Vulvar Skin☆

G. Fleuren, G. Kenter, E. Schuuring, 1997 .

Impact of adjuvant chemotherapy and surgical staging in early-stage ovarian carcinoma: European Organisation for Research and Treatment of Cancer-Adjuvant ChemoTherapy in Ovarian Neoplasm trial.

M. Franchi, I. Vergote, C. Coens, 2003, Journal of the National Cancer Institute.

Comparison of CA-125 and standard definitions of progression of ovarian cancer in the intergroup trial of cisplatin and paclitaxel versus cisplatin and cyclophosphamide.

M. Piccart, E. Eisenhauer, G. Rustin, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results.

M. Piccart, K. Swenerton, B. Zee, 2000, Journal of the National Cancer Institute.

Human papillomavirus infection in squamous cell carcinoma of the vulva, in various synchronous epithelial changes and in normal vulvar skin.

G. Fleuren, G. Kenter, E. Schuuring, 1998, Gynecologic oncology.

Evaluation of a nationwide Dutch guideline to detect Lynch syndrome in patients with endometrial cancer.

A. Wagner, A. V. van Hof, P. Ewing-Graham, 2021, Gynecologic oncology.

Impact of the COVID-19-pandemic on patients with gynecological malignancies undergoing surgery: A Dutch population-based study using data from the ‘Dutch Gynecological Oncology Audit’

W. van Driel, K. Overmars, D. Boll, 2022, Gynecologic Oncology.

Is cisplatin-taxol (PT) the standard treatment in advanced ovarian cancer. The NOCOVA

M. Piccart, S. Kaye, J. Cassidy, 1997 .

Lymph Node Sampling and Taking of Blind Biopsies Are Important Elements of the Surgical Staging of Early Ovarian Cancer

I. Vergote, C. Coens, P. Timmers, 2010, International Journal of Gynecologic Cancer.

Long‐term follow‐up confirms a survival advantage of the paclitaxel–cisplatin regimen over the cyclophosphamide–cisplatin combination in advanced ovarian cancer

M. Piccart, K. Swenerton, I. Vergote, 2003, International journal of gynecological cancer : official journal of the International Gynecological Cancer Society.

Prognostic value of Ic substages in invasive epithelial ovarian carcinoma

A. Zwinderman, J. Trimbos, I. Vergote, 2014 .

Genomic aberrations relate early and advanced stage ovarian cancer

P. V. van Diest, B. Ylstra, G. Meijer, 2012, Cellular Oncology.

Early ovarian cancer

P. Timmers, 2014 .